GENEVA, Nov. 24 -- CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD. (1718 Yueda Road, Changchun High-Tech Dev. ZoneChangchun, Jilin 130012), 长春金赛药业有限责任公司 (中国吉林省长春市高新区越达路1718号) filed a patent application (PCT/CN2025/095163) for "BISPECIFIC ANTIBODY TARGETING EGFR AND HER2 AND ANTIBODY-DRUG CONJUGATE" on May 15, 2025. With publication no. WO/2025/237380, the details related to the patent application was published on Nov 20, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the ...